Vericel (VCEL) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Vericel (VCEL) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 36.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.96% |
| Dec 31, 2025 | 15.31% |
| Sep 30, 2025 | 239.96% |
| Jun 30, 2025 | 66.36% |
| Mar 31, 2025 | -134.11% |
| Dec 31, 2024 | 612.55% |
| Sep 30, 2024 | -12,203.69% |
| Jun 30, 2024 | -8,158.41% |
| Mar 31, 2024 | 33.18% |
| Dec 31, 2023 | 164.85% |
| Sep 30, 2023 | 99.95% |
| Jun 30, 2023 | 99.97% |
| Mar 31, 2023 | 96.76% |
| Dec 31, 2022 | -99.85% |
| Sep 30, 2022 | 98.70% |
| Jun 30, 2022 | 87.82% |
| Mar 31, 2022 | 87.77% |
| Dec 31, 2021 | -66.30% |
| Sep 30, 2021 | -382.12% |
| Jun 30, 2021 | 55.38% |